• יו"ר: פרופ' חיים שירין
  • מזכיר: ד"ר ליאור כ"ץ
  • גזבר: פרופ' ריפעת ספדי
  • חברי איגוד: ד"ר טובה רייניס, ד"ר מיכל אופנהיים, ד"ר נעים אבו-פרחה וד"ר לב ליכטנשטיין
מצגות וכנסים

סיקור הכינוס החצי שנתי של האיגוד הישראלי לגסטרואנטרולוגיה ומחלות כבד

התקיים ב-13-14 ביולי 2021

Session 1: Opening Plenary Session

Welcome address
Haim Shirin, Shamir Medical Center (Assaf Harofeh)

Practical applications of AI in medicine
Noa Dagan, Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv

Is obesity a disease?
Carel le Roux, University College Dublin, Ireland

Characterizing the tumor microbiome and its effects on response to therapy
Ravid Straussman, Weizmann Institute of Science

Session 2: Malignancies

Introduction

CRC screening between 45-49 –should we follow USA?
Elizabeth Half, Rambam Health Care Campus

When should we stop screening?
Nathan Gluck, Tel Aviv Sourasky Medical Center

Colorectal Cancer Screening in the Elderly - Does Increased Prevalence Necessitate Tighter Surveillance?
Suki Mohamad; Abu-baker Fadi; Ovadia Baruch; Gal Oren; Kopelman Yael

Update in desmoid tumors
Revital Kariv, Tel Aviv Sourasky Medical Center

Session 3: Hepatology

Global progress toward viral hepatitis elimination-how different regions and countries doing toward hepatitis elimination (Sponsored by Gilead)
Homie Razavi, Center for Disease Analysis (CDA), Louisville CO, United States

The effect of Direct-Acting Antiviral regimens and telemedicine on the treatment of inmates with chronic hepatitis C infection in Israeli prisons
Vered Richter; Dana Zelnik-Yovel; Miriam Madar; Ron Rabinovitch; Liav Goldstein; Efrat Broide; et al

What is Next for Systemic Therapies for HCC (Sponsored by Roche)
Rifaat Safadi

Pfizer’s SARS-COV-2 vaccine efficacy is significantly reduced after liver transplantation
Amer Johnny; Rifaat Safadi

Session 4: Nutrition

The Hateful (or Grateful) 8: Why Food is Either Medicine or Poison
Robert Lustig, University of California, San Francisco,USA

Local immune response to food antigens drives meal-induced abdominal pain
Guy Boeckxstaens, Katholieke Universiteit Leuven, Belgium

A Mediterranean diet-based nutritional education program positively modifies the intestinal microenvironment of healthy participants: short and long-term results
Sharar Fischler Tali; Godny Lihi; Reshef Leah; Elial-Fatal Sarine; Pfeffer-Gik Tamar; Raykhel Barbara; et al

Disease-specific risk factors for malnutrition development in IBD
Fliss-Isakov Naomi; Einav Larisa; Hirsch Ayal; Ron Yulia; Cohen Nathaniel Aviv; Anbar Ronit; et al

Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for refractory mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial
Levine Arie; Scaldaferri Franco; Sarbagili Shabat Chen; Zittan Eran; Hirsch Ayal; Chiara Mentella Maria; et al

Serum Vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients
Tzadok Roie; Fliss-Isakov Naomi; Cohen Nathaniel Aviv; Ron Yulia; Maharshak Nitsan; Hirsch Ayal

Reservatrol (VINIA): an effective treatment for vascular function and improved Hb1C level and insulin sensitivity
Yochi Hagay

Session 5: IBD

Home-based IBD monitoring and treatment – (Sponsored by Takeda)
Bella Ungar, Sheba Medical Center

Effect of inflammatory bowel disease and related medication on Covid-19 incidence, disease severity and outcome-The Israeli experience
Richter Vered; Bermont Anton; L Cohen Daniel; Broide Efrat; Shirin Haim

Can one (IL23) do things that two cant do (12/23)? - Mechanistic considerations and Lessons from head to head trials (Sponsored by Abbvie)
Mattheu Allez, APHP, Université de Paris, France

Decreased immune response to COVID-19 mRNA vaccine in patients with IBDs treated with anti-TNF: A prospective, multi-center ISRAELI study
Edelman-Klapper Hadar; Zittan Eran; Bar-Gil Shitrit Ariella; Rabinowitz Keren Masha; Goren Idan; Avni-Biron Irit; et al

Tofacitinib for the treatment of ulcerative colitis: up to 6.8 years of safety data from global clinical trials (Sponsored by Pfizer)
Geert D'Haens, Amsterdam University

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease Preliminary Real World Data During Mass Vaccination Campaign
Ben Tov Amir; Banon Tamar; Chodick Gabriel; Kariv Revital; Assa Amit; Gazit Sivan

Session 6: Industry sponsored Session - sponsored by Jannsen

Entertaining the fire - molecular pathways driving inflammation in IBD
Alexsander Moschen, Insburt University, Austria

Ustekinumab in IBD: evidence beyond bionaive patients
Peter Lakatos, McGill University Health Centre, Montreal General Hospital Canada

Session 7: Abstracts

Pneumatic dilation is safe in elderly patients with achalasia : An international multicenter real world cross-sectional study
Bar Nir; Pasricha Trisha Satya; Staller Kyle; Velez Chris David; Thurm Tamar; Ben-Ami Shor Dana; et al

Postoperative endoscopic recurrence in patients with Crohn's disease
Henit Yanay MD

Endoscopy sleeve gastroplasty: The TLVMC first experience
Reicher Relly; Shnell Mati; Poulin Dorel; Ben Yaakov Alona; Fishman Sigal

Sclerosing mesenteritis; A metabolic phenomenon?
Schweistein Hagai; Weintraub Yoav; Hornik-Lurie Tzipi; Haskiya Hassan; Ringel Yehuda; Naftali Timna

Impact of endoscopy and advanced age on the symptomatology and evaluation of patients with esophageal diverticula
Cohen Daniel; Krutouz Ariel; Bermont Anton; Shirin Haim

The FTRD experience at Hadassah Uiversity M.C.
Zlotnick Eitan; Epstein Julia; Itskoviz David; Braverman Michal; Katz Lior; Jacob Harold; et al

Endoscopic Submucosal Dissection (ESD) - An Israeli Single Center Experience
Gal Eyal; Shefer Irina

Session 8: Neurogastroenterology

Pearls about chronic abdominal pain: From diagnosis to treatment.
Qasim Aziz, Wingate Institute of Neurogastroenterology, London, England

Bloating and distention – What did we learn from the Barcelona Group
Dan Livovsky, Sharei Zedek Medical Center

United we stay: Standardization of the protocol and clinical use of Anorectal manometry, Israeli consensus group.
Yoav Mazor, Rambam health Care Campus

Use of trans-perineal ultrasound in addition to trans-rectal ultrasound improves the assessment of anal sphincter integrity in anal incontinence.
Tal Engel

The relevance of "ineffective esophageal motility" in the era of Chicago classification 4.0 (CC4) and the impact of solid swallows
Mari Amir; Azzam Narges; Said Ahmad Helal; Khoury Tawfik; Hadad Haya

Session 9: Surgery in Gastroenterology

Crohn’s disease strictures: Stent? Dilate? Surgery?
Ofer Ben Bassat, Barzilai University Medical Center and Nadav Haim, Shamir Medical Center (Assaf Harofeh)

Management of large sessile rectal polyp
Sergei Vosko, Shamir Medical Center (Assaf Harofeh) and Ido Mizrahi, Hadassah-Hebrew University Medical Center

Colonic Malignant stricture- to stent or not to stent
Eyal Gal, Kaplan Medical Center and Haim Gilshtein, Rambam Medical Center

Session 10: Controversies : 1) The approach to Iron Def. Anemia ; 2) Fentanyl for Sedation

Management of Two Cases – Audience Choices
Nimrod Kimchi, Batyamon Health Center and Clalit Health Services, Israel

Sedation Drugs – The role of Fentanyl
cons
Lev Lichtenstein, Clalit Health Services

Pros
Alice Herskovic, Clalit Health Services

Session 11: Closing Plenary Session

The Israeli COVID-19 vaccination campaign - challenges, successes and unknowns
Tal Brosh, Assuta Ashdod University Hospital

Israel and global view on COVID 19 and IBD - Can we learn anything for other infections in immunosuppressed patients?
Iris Dotan, Rabin Medical Center

Fatty liver disease in the COVID19 era
Rifaat Safadi, Hadassah-Hebrew University Medical Center

נושאים קשורים:  מצגות וכנסים
תגובות